Tillotts Pharma Overview

  • Status

  • Acquired/​Merged

  • Employees

  • 300

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 3

  • Investments

  • 2

Tillotts Pharma General Information

Description

Manufacturer of pharmaceutical products intended for the treatment of gastrointestinal diseases. The company offers medicines for the treatment of gastro-related ailments including the inflamed lining of the large bowel, anti-inflammatory agents and locally acting glucocorticosteroids, macrocyclic anti-bacterial agents formulated as film-coated tablets and granules for oral suspension, antispasmodic for painful bowel cramps and bloating in irritable bowel syndrome, liver disease associated with cystic fibrosis as well as colonoscopy prep.

Contact Information

Website
www.tillotts.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Zeria Pharmaceuticals
Primary Office
  • Baslerstrasse 15
  • 4310 Rheinfelden
  • Switzerland
+41 061 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tillotts Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tillotts Pharma‘s full profile, request access.

Request a free trial

Tillotts Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended for the treatment of gastrointestinal diseases. The company offers medi
Pharmaceuticals
Rheinfelden, Switzerland
300 As of 2023
0000 0000-00-00
000000&0

000 00

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
000000000000000
Liestal, Switzerland
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tillotts Pharma Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 000000 Corporation Liestal, Switzerland
You’re viewing 1 of 1 competitors. Get the full list »

Tillotts Pharma Patents

  • 291

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 13

    Granted

  • 8

    Pending

  • 000

    Expiring in next 12 mo

Tillotts Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019394744-A1 Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof Pending 07-Dec-2018 0000000000
CA-3116947-A1 Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof Pending 07-Dec-2018 0000000000
EP-3891178-A1 Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof Pending 07-Dec-2018 0000000000
JP-2022510175-A Topical treatment of immune checkpoint inhibitor-induced diarrhea, colitis or enteritis using antibodies and fragments thereof Pending 07-Dec-2018 0000000000
US-20220119515-A1 Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof Pending 07-Dec-2018 C07K16/241
To view Tillotts Pharma’s complete patent history, request access »

Tillotts Pharma Executive Team (4)

Name Title Board Seat Contact Info
Thomas Von Kiskér Chief Executive Officer & Board Member
Mattias Norrman Chief Operating Officer
Dirk Reckert Chief Business Development Officer
Marcel Portmann Head of Finance
To view Tillotts Pharma’s complete executive team members history, request access »

Tillotts Pharma Board Members (1)

Name Representing Role Since
000000 000 0000é0 Tillotts Pharma Chief Executive Officer & Board Member 000 0000
To view Tillotts Pharma’s complete board members history, request access »

Tillotts Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tillotts Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tillotts Pharma‘s full profile, request access.

Request a free trial

Tillotts Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000 27-Nov-2020 000000000 00000 Buildings and Property 000000 00
Tillotts Pharma (Entocort) 17-Jul-2015 Corporate Asset Purchase 00000 Buildings and Property 000000 00
To view Tillotts Pharma’s complete investments history, request access »

Tillotts Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000 (0 17-Jul-2015 000000000 00000 00 00000 Completed
  • 00000000 000000
To view Tillotts Pharma’s complete exits history, request access »